| Test Code |
Procedure |
| 300908 |
Abnormal APTT/Prothrombin Time Reflexive Evaluation
(APTT, Prothrombin Time/INR, Thrombin Time) Note: Additional assays as necessary will be performed at an additional charge to determine the cause of the abnormality. |
| 500012 |
Acid Labile Subunit (ALS) |
| |
ACTH - see 500011 -
Adrenocorticotropic Hormone |
| 300716 |
Activated Protein C Resistance (APCR) with Factor V Deficient Plasma |
| 300737 |
Activated Protein C Resistance (APCR) without Factor V Deficient Plasma |
| |
ADH - see 500035 - Anti-Diuretic Hormone |
| 500036 |
21-Hydroxylase Antibodies |
| 500800 |
Adrenal Androgen Profile
(Androstenedione, DHEA-Sulfate, Testosterone) |
| |
Adrenarche, Premature - see 500925
or 500930 - Premature Adrenarche
Profiles |
| 500011 |
Adrenocorticotropic Hormone (ACTH) |
| 500632 |
Alanine Aminotransferase (ALT/SGPT) |
| 500223 |
Albumin |
| 500014 |
Aldosterone, Mass Spectrometry |
| 500633 |
Alkaline Phosphatase |
| 300039 |
Alpha-2-Antiplasmin Assay |
| 500820 |
Alpha Reductase Profile, 5-, (Dihydrotestosterone, Testosterone) |
| 500016 |
Alpha Subunit |
| |
ALS - see 500012 - Acid Labile Subunit |
| 500825 |
Amenorrhea Test Group
(Estradiol, FSH, LH, Prolactin) |
| |
Amenorrhea/Hirsutism -
see also Hirsutism Test Groups |
| 500649 |
Amylase |
| 500026 |
Androstanediol Glucuronide |
| 500030 |
Androstenedione, Mass Spectrometry |
| 300233 |
Anti-Annexin V IgG, IgM *RUO* |
| 300034 |
Anticardiolipin Antibodies, IgA, IgG, IgM |
| 300165 |
Anticardiolipin Antibodies, IgG, IgM |
| 300164 |
Anticardiolipin Antibody, IgA |
| 300161 |
Anticardiolipin Antibody, IgG |
| 300162 |
Anticardiolipin Antibody, IgM |
| 500035 |
Antidiuretic Hormone (ADH) *RUO* |
| |
Anti-Insulin - see 500225 -
Insulin Antibodies |
| 500043 |
Anti-Mullerian Hormone (AMH), Serum *RUO* |
| 300153 |
Antiphosphatidylserine (APTS) IgG, IgM |
| 300918 |
Antiphospholipid Syndrome, Comprehensive (APTT, Immediate APTT Mixing Studies, Anticardiolipin Antibody (IgG, IgM, IgA), Antiphosphatidylserine Antibodies (IgG, IgM), Beta-2-Glycoprotein I Antibodies (IgG, IgM, IgA), Antiprothrombin Antibodies (IgG, IgM), dRVVT, Hexagonal Phospholipid Neutralization, Platelet Neutralization Procedure, Lupus Anticoagulant Interpretation) |
| 300230 |
Antiprothrombin Antibodies IgG, IgM |
| 300030 |
Antithrombin Activity |
| 300033 |
Antithrombin Antigen |
| |
Anti-Thyroid Peroxidase Antibodies -
see 500042 -Thyroid Peroxidase
Antibodies |
| |
APCR - see 300716 - Activated Protein C Resistance |
| 300040 |
APTT |
| 300806 |
APTT Mixing Studies
(APTT, APTT 1:1 NP Mix, APTT 1:1 NP Control Mix, APTT 1:1 Saline Mix, APTT 1:1 NP 60 min. Incubation, APTT 1:1 NP Control 60 min. Incubation) |
| |
Arixtra® - see 300864- Heparin Anti-Xa Fondaparinux |
| 500631 |
Aspartate Aminotransferase (AST/SGOT) |
| 300353 |
AspirinWorks® |
| |
ASU - see 500016 - Alpha Subunit |
| |
B-12 - See 500334 - Vitamin B-12 |
| 300166 |
Beta-2 Glycoprotein I, IgA, IgG, IgM |
| |
Beta-hCG - see 500068 -
Chorionic Gonadotrophin, Human |
| 500635 |
Bicarbonate (CO2) |
| 500659 |
Bilirubin, Direct |
| 500620 |
Bilirubin, Total |
| |
Bioavailable Testosterone - see
500288 - Testosterone, Bioavailable |
| 300909 |
Bleeding Diathesis with Normal APTT/PT Profile (Factor VIII Activity, Factor VIII Chromogenic Activity, Factor IX Activity, Factor XI Activity, Fibrinogen Activity, von Willebrand Factor Antigen, von Willebrand Factor Activity, Factor XIII Activity*RUO*, Plasminogen Activator Inhibitor - 1 Activity, Euglobulin Lysis Time, Alpha 2 Antiplasmin Assay) |
| 500636 |
Blood Urea Nitrogen |
| 300160 |
C4b Binding Protein *RUO* |
| 504006 |
CAHDetxTM by PCR |
| 500830 |
CAH Pediatric Profile 1: 21-OH Deficiency Screen
(Androstenedione, Cortisol, DHEA, 17-OH-Progesterone, Testosterone) |
| 500835 |
CAH Pediatric Profile 2: 11-OH Deficiency Screen
(Androstenedione, Specific S, Cortisol, DHEA, 17-OH-Progesterone, Testosterone) |
| 500845 |
CAH Pediatric Profile 3: 17-OH-Deficiency Screen
(Corticosterone, Cortisol, DHEA, 17-OH-Progesterone, Progesterone) |
| 500850 |
CAH Pediatric Profile 4: 3B-HSD Deficiency Screen
(Androstenedione, Cortisol, DHEA, 17-OH-Pregnenolone, 17-OH-Progesterone) |
| 500860 |
CAH Pediatric Profile 5: 17,20 Desmolase Deficiency
(Androstenedione, Cortisol, DHEA, 17-OH-Pregnenolone, Progesterone, 17-OH-Progesterone, Testosterone) |
| 500865 |
CAH Pediatric Profile 6: Comprehensive Screen
(Androstenedione, Specific S, Cortisol, DHEA, DOC, 17-OH-Pregnenolone, Progesterone, 17-OH-Progesterone, Testosterone) |
| 500870 |
CAH Pediatric Profile 7: Treatment Profile (Androstenedione, 17-OH-Progesterone, Testosterone) |
| 500805 |
CAH Test Group I Adult (Late Onset) (Androstenedione, Cortisol, Specific S, DHEA, 17-OH-Progesterone) |
| 500810 |
CAH Test Group II Adult (Late Onset) (Androstenedione, Cortisol, DHEA, 17-OH-Pregnenolone, 17-OH-Progesterone) |
| 500815 |
CAH Test Group III Adult (Late Onset) (Androstenedione, Cortisol, Specific S, DHEA, 17-OH-Pregnenolone, 17-OH-Progesterone) |
| 500047 |
Calcitonin |
| 500637 |
Calcium |
| 500984 |
Catecholamine Test Group, Urine
(Total Catecholamines, Total Metanephrines, VMA, Creatinine) |
| 500062 |
Catecholamines, Fractionated, Urine (Epinephrine, Norepinephrine, Creatinine) |
| 500060 |
Catecholamines, Total, Urine (Includes Creatinine) |
| |
CBA - see 300314 - Collagen Binding Assay |
| 500641 |
Chloride |
| 500601 |
Cholesterol |
| 500068 |
Chorionic Gonadotrophin, Human (Beta-hCG), Quantitative |
| 300314 |
Collagen Binding Assay
(VWF collagen binding activity *RUO*, VWF antigen, Collagen binding ratio) |
| |
Compound S - see 500136 -
11-Desoxycortisol (For Metyrapone
Test) and 500132 - 11-Desoxycortisol
(Specific Compound S) |
| |
Congenital Adrenal Hyperplasia (CAH)
- see CAH Pediatric Profiles, CAH Adult Test Groups and CAHDetx |
| 300924 |
Contact Factor Evaluation
(Factor XI Activity, Factor XII Activity, High Molecular Weight Kininogen
(Fitzgerald Factor) Assay, Prekallikrein (Fletcher Factor ) Assay) |
| 500076 |
Corticosteroid Binding Globulin (CBG) |
| 500084 |
Corticosterone |
| 500080 |
Cortisol, Free, Serum (Free Cortisol, Serum Cortisol, CBG) |
| 500102 |
Cortisol, Free, Urine (Includes Creatinine) |
| 500094 |
Salivary Cortisol, LC/MS-MS |
| 500092 |
Cortisol, Serum or Plasma, Mass Spectrometry |
| 500104 |
C-Peptide, Plasma |
| 500108 |
C-Peptide, Urine (Includes Creatinine) |
| 300312 |
C-Reactive Protein, High Sensitivity
(hs CRP) |
| 500750 |
Creatine Kinase |
| 500634 |
Creatinine |
| 500385 |
Creatinine Clearance |
| 300203 |
Cryofibrinogen |
| 300415 |
D-Dimer Quantitative (Automated) |
| 500116 |
Dehydroepiandrosterone (DHEA) |
| 500120 |
Dehydroepiandrosterone Sulfate (DHEA-S), Mass Spectrometry |
| 500124 |
Deoxycorticosterone (DOC) |
| 500136 |
Desoxycortisol, 11-, (Compound S for Metyrapone test) |
| 500132 |
Desoxycortisol, 11-,
(Specific Compound S) |
| 500140 |
Dexamethasone, Mass Spectrometry |
| |
DHEA - see - 500116
Dehydroepiandrosterone |
| |
DHEA - Sulfate - see 500120 - Dehydroepiandrosterone Sulfate |
| |
DHT - see 500144 -
Dihydrotestosterone |
| |
Diabetes - see also 500878 and
500879 - Islet Cell Dysfunction Test
Groups I and II |
| 500877 |
Diabetes Autoimmune Test Group
(Insulin Abs, GAD-65 Abs, ICA512 Abs) |
| 500144 |
Dihydrotestosterone (DHT), Mass Spectrometry |
| 300057 |
Dilute Russell's Viper Venom Test
(DRVVT) |
| |
DOC - see 500124 - Deoxycorticosterone |
| |
Drug Induced Platelet Antibody - see 300521 - Platelet Antibody, Drug Induced |
| 300814 |
Ecarin Clotting Time *RUO* |
| 501462 |
Electrolyte Panel |
| |
Epinephrine (Adrenaline) – see -500062 Catecholamines, Fractionated, Urine |
| 500152 |
Estradiol, Serum |
| 501193 |
Estriol, Unconjugated (Free) |
| 500148 |
Estrogens, Total |
| 500172 |
Estrone, Serum |
| 300403 |
Euglobulin Lysis Time |
| 300920 |
Extrinsic Pathway Coagulation Factor Profile (Factor II Activity, Factor V Activity, Factor VII Activity, Factor X Activity) |
| 300700 |
Factor Inhibitor Screen (APTT, PT, Thrombin Time, APTT 1:1 NP, APTT 1:1 Saline, APTT 1:1 NP 60 min. incubation, APTT 1:1 NP Control 60 min. incubation, Inhibitor Screen interpretation) |
| 300100 |
Factor II Activity (Prothrombin Activity) |
| 120736 |
Factor II Gene Mutation (Prothrombin G20210A) |
| 300724 |
Factor II Inhibitor (Bethesda)
(APTT, PT, PT 1:1 NP, PT 1:1 NP 60 min. incubation, PT 1:1 NP control 60 min. incubation, Factor II Activity, Factor II Bethesda Titer) |
| 300101 |
Factor V Activity |
| 300706 |
Factor V Inhibitor (Bethesda)
(APTT, PT, PT 1:1 NP, Factor V Activity, Factor V Bethesda Titer) |
| 120719 |
Factor V Leiden Mutation |
| 300102 |
Factor VII Activity |
| 300112 |
Factor VII Antigen *RUO* |
| 300721 |
Factor VII Inhibitor (Bethesda) (APTT, PT, PT 1:1 NP, Factor VII Activity, Factor VII Bethesda Titer) |
| 300103 |
Factor VIII Activity |
| 300208 |
Factor VIII Quantitation (Non-functional) |
| 300188 |
Factor VIII Bethesda Titer
(Factor VIII Activity and Factor VIII Bethesda titer only) |
| 300214 |
Factor VIII Chromogenic Activity |
| 300701 |
Factor VIII Inhibitor Human (Bethesda)
(APTT, APTT 1:1 NP, APTT 1:1 saline, APTT 1:1 NP 60 min. incubation, APTT 1:1 NP control 60 min. incubation, Factor VIII Activity, Factor VIII Bethesda Titer) |
| |
Factor VIII Related Antigen - see 300113 - von Willebrand Factor Antigen |
| 300104 |
Factor IX Activity |
| 300205 |
Factor IX Antigen |
| 300189 |
Factor IX Bethesda Titer
(Factor IX Activity and Factor IX Bethesda titer only) |
| 300704 |
Factor IX Inhibitor (Bethesda) (APTT, APTT 1:1 NP, APTT 1:1 saline, APTT 1:1 NP 60 min. incubation, APTT 1:1 NP control 60 min. incubation, Factor IX Activity, Factor IX Bethesda Titer) |
| 300105 |
Factor X Activity |
| 300206 |
Factor X Antigen *RUO* |
| 300211 |
Factor X Chromogenic Activity, Vitamin K Antagonist Therapy |
| 300725 |
Factor X Inhibitor (Bethesda)
(APTT, PT, PT 1:1 NP, PT 1:1 NP 60 minute incubation, PT 1:1 NP control 60 minute incubation, Factor X Activity, Factor X Bethesda Titer) |
| 300106 |
Factor XI Activity |
| 300707 |
Factor XI Inhibitor (Bethesda)
(APTT, APTT 1:1 NP, APTT 1:1 saline, APTT 1:1 NP 60 min. incubation, APTT 1:1 NP control 60 min. incubation, Factor XI Activity, Factor XI Bethesda Titer) |
| 300107 |
Factor XII Activity |
| 300708 |
Factor XII Inhibitor (Bethesda)
(APTT, APTT 1:1 NP, APTT 1:1 saline, APTT 1:1 NP 60 min. incubation, APTT 1:1 NP control 60 min. incubation, Factor XII Activity, Factor XII Bethesda Titer) |
| 300108 |
Factor XIII Activity *RUO* |
| 300309 |
Factor XIII Inhibitor Profile *RUO* (Factor XIII Activity, Factor XIII Inhibitor Screen, Factor XIII Titer) |
| 300308 |
Factor XIII Inhibitor Screen *RUO* |
| |
FDP - see 300201 - Fibrin Degradation Products (FDP) |
| 500180 |
Ferritin, Serum |
| 300201 |
Fibrin Degradation Products (FDP) |
| 300202 |
Soluble Fibrin Monomer, Qualitative |
| 300200 |
Fibrinogen Activity |
| 300199 |
Fibrinogen Antigen |
| 300925 |
Fibrinogen Evaluation
(Fibrinogen Activity, Fibrinogen Antigen, Reptilase Time, Thrombin Time, Thrombin Time Mixing Studies) |
| 300913 |
Fibrinolysis Evaluation
(Alpha-2-Antiplasmin, D-Dimer Quantitative, Euglobulin Lysis Time, Fibrin Degradation Products, Plasminogen Activator Inhibitor-1 Activity, Plasminogen Activity, Tissue
Plasminogen Activator Antigen) |
| |
Fitzgerald Factor (HMW Kininogen) - see - 300123 - High Molecular Weight Kininogen |
| |
Fletcher Factor (Prekallikrein) Assay - see - 300121 Preallikrein Assay |
| 500192 |
Follicle Stimulating Hormone (FSH) ECL |
| |
Free and Total Insulin - see 500226 -
Insulin, Free and Total |
| |
Free Cortisol - see 500080, Cortisol,
Free |
| |
Free T-3 - see 500325 -
Triiodothyronine, Free |
| |
Free T-3 Only - see 500323 - Triiodothyronine, Free |
| |
Free Testosterone - see 500290 -
Testosterone, Free |
| 500608 |
Fructosamine |
| |
FSP (Fibrin Split Products) - see 300201 - Fibrin Degradation Products (FDP) |
| |
GAD-65 - see 500236 - Glutamic Acid
Decarboxylase Autoantibodies |
| 500646 |
Gamma Glutamyl Transferase |
| 500797 |
Glucose, Plasma |
| 501190 |
Glucose, Serum |
| 500236 |
Glutamic Acid Decarboxylase (GAD-65) Autoantibodies |
| 500609 |
GlycoMark® |
| 500890 |
Growth Assessment Test Group I
(Growth Hormone, IGF-I) |
| 500891 |
Growth Assessment Test Group II
(IGF-I, IGF-II) |
| 500892 |
Growth Assessment Test Group III
(Growth Hormone, IGF-I, IGF-II) |
| 500893 |
Growth Assessment Test Group IV
(Growth Hormone, IGFBP-3) |
| 500894 |
Growth Assessment Test Group V
(IGF-I, IGFBP-3) |
| 500896 |
Growth Assessment Test Group VI
(IGF-I, IGF-II, IGFBP-3) |
| 500901 |
Growth Assessment Test Group X
(Growth Hormone, IGF-I, IGF-II, IGFBP-3) |
| 500214 |
Growth Hormone Antibodies |
| 500209 |
Growth Hormone Binding Protein (GHBP) |
| 500213 |
Growth Hormone, ICMA |
| 500212 |
Growth Hormone, RIA |
| 500211 |
Growth Hormone, Urine (Includes Creatinine) |
| 500902 |
Growth Receptor Test Group I
(Growth Hormone, IGF-I, IGFBP-3, GH Binding Protein) |
| 500903 |
Growth Receptor Test Group II
(Growth Hormone, IGF-I, IGF-II, IGFBP-3, GH Binding Protein) |
| 500602 |
HDL Cholesterol |
| 300917 |
Heart Disease and Stroke Risk Profile (Fibrinogen Activity, High Sensitivity CRP, Homocysteine, Lipoprotein (a), von Willebrand Factor Antigen, AspirinWorks, Factor VIII activity) |
| 502080 |
Hemoglobin A1c (Glycosylated Hemoglobin, Hemoglobin A1c, Estimated Average Glucose) |
| 300600 |
Heparin Anti-Xa (Unfractionated) |
| 300864 |
Heparin Anti-Xa Fondaparinux (Arixtra®) |
| 300602 |
Heparin Anti-Xa LMWH
(Dalteparin, Enoxaparin) |
| 300133 |
Heparin Cofactor II *RUO* |
| |
Heparin Induced Antibody Assay, Functional see 300082 - Serotonin Release Assasy (C4) |
| 300522 |
Heparin-Induced Platelet Antibody, Immunologic
(Heparin Induced Antibody, HITA normalized OD ratio) |
| 300528 |
Heparin-Induced Antibody Titer |
| 300139 |
Heparin Solution Quantitative Assay |
| 500696 |
Hepatic Function Panel
(Albumin, Total Bilirubin, Direct Bilirubin, Alkaline Phosphatase, Total Protein, ALT, AST) |
| 300144 |
Hexagonal Phospholipid Neutralization |
| 300123 |
High Molecular Weight Kininogen (Fitzgerald Factor Assay) |
| |
See 300312 - C-Reactive Protein, High Sensitivity |
| 500895 |
Hirsutism Test Group I
(DHEA-S, Testosterone, Free Testosterone, % Free Testosterone by Dialysis, SHBG) |
| 500994 |
Hirsutism Test Group I with with Bioavailable Testosterone
(DHEA-S, Testosterone, Bioavailable Testosterone, SHBG) |
| 500900 |
Hirsutism Test Group II
(Androstenedione, DHEA-S, Testosterone, Free Testosterone, % Free Testosterone, SHBG) |
| 500995 |
Hirsutism Test Group II with Bioavailable Testosterone (Androstenedione, DHEA-S, Testosterone, Bioavailable Testosterone, SHBG) |
| 500905 |
Hirsutism Test Group III
(Androstanediol Glucuronide, DHEA-S, Testosterone, Free Testosterone, % Free Testosterone, SHBG) |
| 500996 |
Hirsutism Test Group III with Bioavailable Testosterone (Androstanediol Glucuronide, DHEA-S, Testosterone, Bioavailable Testosterone, SHBG) |
| 500910 |
Hirsutism Test Group IV
(Androstanediol Glucuronide, Androstenedione, DHEA-S, Testosterone, Free Testosterone, % Free Testosterone, SHBG) |
| 500997 |
Hirsutism Test Group IV with Bioavailable Testosterone (Androstanediol Glucuronide, Androstenedione, DHEA-S, Testosterone, Bioavailable Testosterone, SHBG) |
| 300727 |
Homocysteine |
| 500218 |
Homovanillic Acid (HVA), Urine
(Includes Creatinine) |
| 300531 |
HPA-1a (PLA-1Platelet Antigen) Genotyping (PLA2 Polymorphism Detection) |
| 300734 |
HR2 Haplotype (Factor V HR2), A4070G Polymorphism |
| 500088 |
Hydroxycorticosterone, 18, Mass Spectrometry |
| 500215 |
Hydroxyindoleacetic Acid, 5- (5-HIAA), Urine (Includes Creatinine) |
| 500262 |
Hydroxypregnenolone, 17- |
| 500270 |
Hydroxyprogesterone, 17a-, (17-OHP) |
| 500871 |
Hypoglycemia Test Group I
(Cortisol, Glucose, Growth Hormone, Insulin) |
| 500255 |
ICA-512 Autoantibodies |
| 500283 |
IGF Binding Protein-1 (IGFBP-1) |
| 500284 |
IGF Binding Protein-2 (IGFBP-2) |
| 500281 |
IGF Binding Protein-3 (IGFBP-3) |
| 500282 |
IGF-I |
| 500220 |
Insulin |
| 500225 |
Insulin Antibodies |
| 500226 |
Insulin, Free and Total |
| |
Insulin-like Growth Factor Binding
Proteins - see 500283 - IGFBP-1,
500284 - IGFBP-2, 500281 - IGFBP-3 |
| |
Insulin-like Growth Factors -
see 500282 - IGF-I or 500228 - IGF-II |
| 300921 |
Intrinsic Pathway Coagulation Factor Profile (Factor VIII Activity, Factor IX Activity, Factor XI Activity, Factor XII Activity) |
| 500648 |
Iron |
| |
Islet Cell Antibodies - see 500255 -
ICA-512 Autoantibodies or 500877,
500878, 500879 - Diabetes Test Groups |
| 500878 |
Islet Cell Dysfunction Test Group I
(Insulin, Proinsulin, Proinsulin:Insulin Ratio) |
| 500879 |
Islet Cell Dysfunction Test Group II (Glucose, Insulin, Proinsulin, Proinsulin:Insulin Ratio) |
| 300056 |
Kaolin Clotting Time (KCT) |
| 500642 |
Lactic Acid (Lactate) Dehydrogenase (LDH) |
| |
LDH - see 500642 - Lactic Acid
Dehydrogenase |
| 500604 |
LDL Direct |
| 500237 |
Leptin *RUO* |
| 500708 |
Lipase |
| 501464 |
Lipid Panel
(Cholesterol, HDL, Triglycerides) |
| 300715 |
Lipoprotein (a) |
| 300916 |
Lupus Anticoagulant and Antiphospholipid Antibody Confirmatory Profile (APTT, Immediate APTT Mixing Studies, Prothrombin Time/INR, Anticardiolipin Antibody (IgG, IgM), dRVVT, Thrombin Time, Hexagonal Phospholipid Neutralization, Platelet Neutralization Procedure, beta-2 Glycoprotein I IgG, IgA, IgM, Lupus Anticoagulant Interpretation) |
| 300906 |
Lupus Anticoagulant and
Antiphospholipid Antibody Profile (APTT, Immediate APTT Mixing Studies, Prothrombin Time/INR, Anticardiolipin Antibody (IgG, IgM), dRVVT, Thrombin Time, Hexagonal Phospholipid Neutralization, beta-2 Glycoprotein I IgG, IgA, IgM, Lupus Anticoagulant Interpretation) |
| 500234 |
Luteinizing Hormone (LH) ECL |
| 500375 |
Macroprolactin |
| 500652 |
Magnesium |
| 300939 |
Markers of Coagulation Activation
(Thrombin-Antithrombin Complex (TAT), Prothrombin Fragment 1.2, D-Dimer quant) |
| 500941 |
Menopausal Test Group (Postmenopausal) (Estradiol, FSH, LH) |
| 300934 |
Menorrhagia Profile (APTT, Prothrombin Time/INR, Thrombin Time, Factor VIII Activity, von Willebrand Factor Activity, von Willebrand Factor Antigen, Factor IX Activity, Factor XI Activity) |
| 501461 |
Metabolic Panel, Basic
(Calcium, BUN, Glucose (serum), Creatinine, Sodium, Chloride, Potassium, Bicarbonate) |
| 501463 |
Metabolic Panel, Comprehensive
(AST, ALT, Alkaline, Phosphatase, BUN, Creatinine, Calcium, Glucose (serum), Total Bilirubin, Sodium, Potassium, Chloride, Bicarbonate, Albumin, Total Protein) |
| 500240 |
Metanephrines, Fractionated Urine (Metanephrine, Normetanephrine, Creatinine) |
| 500242 |
Metanephrines, Total, Urine (Includes Creatinine) |
| 500915 |
Mineralocorticoid Adult Test Group (Aldosterone, Corticosterone, 18-OH-Corticosterone, Deoxycorticosterone) |
| 500920 |
Mineralocorticoid Pediatric Profile (Aldosterone, Corticosterone, 18-OH-Corticosterone, Deoxycorticosterone) |
| 300711 |
MMP-9 *RUO*
(Matrix Metalloproteinase-9)
|
| |
Mullerian Inhibiting Substance (MIS) - see 500043 - Anti-Mullerian Hormone |
| 300933 |
Oral Contraceptive/Hormone Replacement Therapy Thrombotic Risk Evaluation
(Antithrombin Activity, Factor II Gene Mutation (Prothrombin G20210A), Factor V Leiden, Protein C Activity, Protein S Antigen Free) |
| 500246 |
Parathyroid Hormone, Intact (IPTH) (Includes Calcium) |
| 300995 |
Pathologist Interpretation |
| |
PF4 Antibody - see 300522 - Heparin Induced Platelet Antibody, Immunologic |
| 500638 |
Phosphorus, Serum |
| 300726 |
PIVKA-II *RUO* |
| |
Plasma Renin Activity - see 500278 -
Renin, Plasma |
| 300128 |
Plasminogen Activator Inhibitor-1
(PAI-1) Antigen |
| 129100 |
Plasminogen Activator Inhibitor-1, 4G/5G Genotyping *RUO* (PAI-1 polymorphism) |
| 300400 |
Plasminogen Activity |
| 300408 |
Plasminogen Antigen |
| 300386 |
Platelet Antibody, Direct |
| 300521 |
Platelet Antibody Drug-Induced*** |
| 300520 |
Indirect Antiplatelet Alloantibody Profile |
| 300504 |
Platelet Factor 4 |
| 300805 |
Platelet Neutralization Procedure |
| 300524 |
Platelet HPA-1a/1b Antibody Identification |
| |
Platelet Specific Antigen PLA1 (HPA-1a) - see 300531 - HPA-1a (PLA 1 Platelet Antigen Genotyping PLA 2 Polymorphism Detection) |
| |
Platelet Specific Antigen-2 (PLA2)
Polymorphism (HPA-1b) - see 300531- HPA-1a (PLA 1 Platelet Antigen Genotyping PLA 2 Polymorphism Detection)
|
| 500640 |
Potassium, Serum |
| 500258 |
Pregnenolone |
| 300121 |
Prekallikrein (Fletcher Factor) Assay |
| 500925 |
Premature Adrenarche Profile I (Androstenedione, DHEA-S, 17-OH-Progesterone, Testosterone) |
| 500930 |
Premature Adrenarche Profile II (Androstenedione, DHEA, 17-OH-Pregnenolone, 17-OH-Progesterone, Testosterone) |
| 500266 |
Progesterone, Mass Spectrometry |
| |
Progesterone, 17a-OH—see 500270 -
Hydroxyprogesterone, 17a- |
| 500272 |
Proinsulin |
| 500274 |
Prolactin, Serum (ICMA) |
| |
Prolactin, Macro- see 500375 - Macroprolactin |
| |
Prolonged Prothrombin Time or APTT - see 300908 - Abnormal APTT/Prothrombin Time Evaluation |
| 300204 |
Protein C Activity and Protein S Activity, Protein C Antigen and Protein S Antigen, Total |
| 300149 |
Protein C Activity and Protein S Activity |
| 300177 |
Protein C Activity and Protein S Antigen, Free |
| 300142 |
Protein C Antigen and Protein S Antigen, Total |
| 300035 |
Protein C Activity (Chromogenic) |
| 300036 |
Protein C Antigen |
| 300067 |
Protein C Antigen/Factor VII Antigen Ratio *RUO*
|
| 300032 |
Protein C Antigen, Protein S Antigen/ Factor VII Antigen Ratios *RUO* |
| 300088 |
Protein S Activity |
| 300087 |
Protein S Antigen, Free |
| 300038 |
Protein S Antigen, Total |
| 300929 |
Protein S Antigen, Total and Free |
| 300059 |
Protein S Antigen/Factor VII Antigen Ratio *RUO* |
| 300928 |
Protein S Profile (Protein S Activity (clot), Protein S Antigen Free, Protein S Antigen Total) |
| 300340 |
Protein Z Antigen *RUO* |
| 300718 |
Prothrombin Fragment 1+ 2, monoclonal |
| |
Prothrombin Gene 20210A Mutation
(Factor II Mutation) - see 120736 - Factor II Gene Mutation (Prothrombin G20210A) |
| |
Prothrombin Time Abnormal Evaluation- see 300908 - Abnormal APTT/Prothrombin Time Evaluation |
| 300080 |
Prothrombin Time/INR |
| 300116 |
Prothrombin Time Mixing Studies:
PT, PT 1:1 NP, PT 1:1 NP 60 min. incubation, PT 1:1 NP 60 min. incubation control |
| |
PTH, Intact - see 500246 - Parathyroid
Hormone, Intact (PTH) |
| 300915 |
Recurrent Miscarriage/Fetal Demise Obstetric Complications Profile (APTT, Immediate APTT Mixing Studies, Anticardiolipin Antibody (IgG, IgM, IgA), Antiphosphatidylserine Antibody (IgG, IgM), Antithrombin Activity, Beta-2 Glycoprotein I Antibody (IgG, IgM, IgA), dRVVT, Factor II Gene Mutation (Prothrombin G20210A), Factor V Mutation (Leiden), Factor XIII Activity*RUO*, Hexagonal Phospholipid Neutralization, Homocysteine, Protein C Activity (Chromogenic), Protein S Antigen Free, Lupus Anticoagulant Interpretation) |
| 501465 |
Renal Function Panel
(Albumin, Sodium, Chloride, Potassium, Bicarbonate, Creatinine, Glucose (serum), Phosphorus, BUN, Calcium) |
| 500278 |
Renin, Plasma (Plasma Renin Activity) |
| 300940 |
Reproductive Health Thrombophilia Profile, Screening (APTT, Immediate APTT Mixing Studies, Factor XIII*RUO*, Factor II Gene Mutation (Proghrombin G20210A), Factor V Leiden Mutation, Hexagonal Phospholipid Neutralization, Antithrombin Activity, Protein C Activity (Chromagenic), Protein S Antigen Free, Anticardiolipin Antibody (IgG, IgM), Homocysteine, beta-2 Glycoprotein I (IgG, IgA, IgM), Lupus Anticoagulant Interpretation) |
| 300941 |
Reproductive Health Thrombophilia Profile, Comprehensive (APTT, Immediate APTT mixing studies, beta-2 Glycoprotein I, IgG, IgM, IgA, Antiphosphatidylserine, IgG and IgM, Anti-Annexin V, IgG and IgM*RUO*, Anticardiolipin Antibody (IgG, IgM), Anti-Prothrombin IgG and IgM, dRVVT, Hexagonal Phospholipid Neutralization, Antithrombin Activity, Protein C Activity (chromogenic), Protein S Antigen, Free, Factor XIII Activity*RUO*, Homocysteine, Lipoprotein (a), Factor II Gene Mutation (Prothrombin G20210A), Factor V Leiden Mutation, Lupus Anticoagulant) |
| 300610 |
Reptilase Time |
| |
Reverse T-3 - see 500326 -
Triiodothyronine, Reverse |
| |
Ristocetin Cofactor - See 300114 -
von Willebrand Factor Activity |
| 300082 |
Serotonin Release Assay (SRA), Unfractionated Heparin (UNF) |
| 500299 |
Sex Hormone Binding Globulin (SHBG), Serum |
| 504005 |
SHOX-DNA-DxTM |
| 500639 |
Sodium |
| |
Somatomedin C - see 500282 - IGF I |
| |
Specific Compound S - see 500132 -
Desoxycortisol, 11- |
| |
Specific S - see 500132 -
11-Desoxycortisol |
| 300611 |
Stypven Time *RUO* |
| 500990 |
Testicular Function Complete Testosterone Evaluation Group
(Testosterone, Free Testosterone, Bioavailable Testosterone, SHBG) |
| 500950 |
Testicular Function Group I
(FSH, LH, Testosterone) |
| 500991 |
Testicular Function Group I with Bioavailable Testosterone (FSH, LH, Testosterone, Bioavailable Testosterone, SHBG) |
| 500955 |
Testicular Function Group II with Bioavailable Testosterone
(FSH, LH, Prolactin, Testosterone) |
| 500992 |
Testicular Function Group II with Bioavailable Testosterone (FSH, LH, Prolactin, Testosterone, Bioavailable Testosterone, SHBG) |
| 500960 |
Testicular Function Group III
(Estradiol, FSH, LH, Prolactin, Testosterone) |
| 500993 |
Testicular Function Group III with Bioavailable Testosterone (Estradiol, FSH, LH, Prolactin, Testosterone, Bioavailable Testosterone, SHBG) |
| 500288 |
Testosterone, Bioavailable, with SHBG (Testosterone, Bioavailable Testosterone, SHBG) |
| 500290 |
Testosterone, Free, with SHBG
(Total Testosterone, Free Testosterone, SHBG) |
| 500286 |
Testosterone, Total, Serum, Mass Spectrometry |
| 501475 |
Testosterone, Total and Free |
| 129260 |
ThrombAssureTM (Factor II Gene Mutation (Prothrombin G20210A) , Factor V Leiden Mutation) |
| 300368 |
ThrombAssure PlusTM (Factor II Gene Mutation (Prothrombin G20210A), Factor V Leiden Mutation, MTHFR C677T and A1298C) |
| 300931 |
ThrombAssure EnhancedTM (Factor II Gene Mutation (Prothrombin G20210A), Factor V Leiden Mutation, APTT, Immediate APTT Mixing Studies, Anticardiolipin Antibody (IgG, IgM, IgA), Antithrombin Activity, dRVVT, Hexagonal Phospholipid Neutralization, Homocysteine, Protein C Activity, Protein S Antigen Free, beta-2 Glycoprotein I (IgG, IgA, IgM), Lupus Anticoagulant Interpretation) |
| 300932 |
ThrombAssure InheritedTM
(Factor II Gene Mutation (Prothrombin G20210A), Factor V Leiden Mutation, Antithrombin Activity Plasma, Protein C Activity, Protein S Antigen Free) |
| 300714 |
Thrombin-Antithrombin Complex |
| 300807 |
Thrombin Time |
| 300813 |
Thrombin Time Mixing Studies
(Thrombin Time, Thrombin Time 1:1 NP Mix, Thrombin Time Heparin Neutralization) |
| 300907 |
Thrombotic Marker Profile (D-Dimer Quantitative, Fibrin Monomer, Prothrombin Fragment 1+2, Thrombin-Antithrombin Complex) |
| 500316 |
Thyroglobulin (w/Anti-thyroglobulin screen), Comprehensive |
| 500038 |
Anti-Thyroglobulin Antibodies (Anti-Tg) |
| 500975 |
Thyroid Function, Adult Hyperthyroid Test Group (T-3, T-4, T-3 Uptake, Free T-4 Index) |
| 500979 |
Thyroid Function, Adult Hyperthyroid/TBG Test Group
(T-3, T-4, TBG) |
| 500977 |
Thyroid Function, Adult Hyperthyroid/TSH Suppression Test Group (TSH-ICMA, T-3, T-4, T-3 Uptake, Free T-4 Index) |
| 500970 |
Thyroid Function, Adult Hypothyroid Test Group (TSH-ICMA, T-4, T-3 Uptake, FT4 Index) |
| 500971 |
Thyroid Function, Adult Hypothyroid/TBG Test Group I (T-4, TBG, TSH-ICMA) |
| 500976 |
Thyroid Function, Adult Hypothyroid/TBG Test Group II
(T4, TBG, TSH-ICMA, Free T-4) |
| 500967 |
Thyroid Function, Adult Special Thyroid Test Group
(T-3, T-4, TSH ICMA) |
| 500965 |
Thyroid Function, Adult Thyroid Test Group (T-4 , T-3 Uptake, FT-4 Index) |
| 500968 |
Thyroid Function, Adult Thyroid/TBG Test Group
(T4, TBG) |
| 500972 |
Thyroid Function, Neonatal Hypothyroid Test Group
(T-4, Anti-thyroglobulin Antibodies, Thyroglobulin, TSH-ICMA) |
| 500978 |
Thyroid Function, Pediatric Hyperthyroid/TBG Test Group
(T-3, T-4, TBG) |
| 500969 |
Thyroid Function, Pediatric Hypothyroid/TBG Test Group I
(T-4, TBG, TSH-ICMA) |
| 500974 |
Thyroid Function, Pediatric Hypothyroid/TBG Test Group II
(T-4, TBG, TSH-ICMA, Free T-4) |
| 500980 |
Thyroid Function, Pediatric Thyroid Autoantibodies Test Group
(Thyroglobulin Abs, Thyroid Peroxidase Abs) |
| 500966 |
Thyroid Function, Pediatric Thyroid/TBG Test Group
(T-4, TBG) |
| 500042 |
Thyroid Peroxidase Antibodies (Anti-TPO) |
| 500305 |
Thyroid Stimulating Hormone (TSH), ICMA |
| 500310 |
Thyroxine (T-4) |
| 500318 |
Thyroxine Binding Globulin (TBG) |
| 504001 |
Thyroxine, Free (FT4), Automated Analog Immunoassay |
| 300134 |
Tissue Plasminogen Activator (TPA)
Activity |
| 300125 |
Tissue Plasminogen Activator (TPA)
Antigen |
| 300804 |
Tissue Thromboplastin Inhibition Test
(TTIT) |
| 500707 |
Total Iron Binding Capacity |
| 500644 |
Total Protein |
| |
TRAb - see 500308 - TSH Receptor
Antibody |
| 500772 |
Transferrin |
| 500745 |
Transferrin Saturation, Serum (Iron, Transferrin) |
| 500603 |
Triglycerides |
| 500322 |
Triiodothyronine (T-3) |
| 500325 |
Triiodothyronine, Free (Includes T-3) (Free T-3, T3) |
| 500323 |
Triiodothyronine, Free Only |
| 500326 |
Triiodothyronine, Reverse |
| 500308 |
TSH Receptor Antibody (TRAb/TBII) |
| 500643 |
Uric Acid |
| 500330 |
Vanillylmandelic Acid (VMA), Urine (Includes Creatinine) |
| 300914 |
Venous Occlusion Evaluation
(Plasminogen Activator Inhibitor - 1 Activity - Pre-occlusion, Tissue Plasminogen Activator Antigen - Pre-occlusion, Tissue Plasminogen Activator Antigen - Post-occlusion) |
| 300901 |
Venous Thrombosis (Hypercoagulability) Profile (APTT, Immediate APTT Mixing Studies, Activated Protein C Resistance, Factor V Leiden Mutation, Anticardiolipin Antibody (IgG, IgM), Antithrombin Activity, Factor II Gene Mutation (Prothrombin G20210A), dRVVT, Hexagonal Phospholipid Neutralization, Homocysteine, Protein C Activity (Chromogenic), Protein S Antigen Free, Factor VIII Activity, beta-2 Glycoprotein I IgG, IgA, IgM, Lupus Anticoagulant Interpretation) |
| 300366 |
Appended Venous Thrombosis Profile (Factor IX Activity, Factor XI Activity, Fibrinogen Activity, Fibrinogen Antigen, Lipoprotein) |
| 300903 |
Venous Thrombosis (Hypercoagulability) Evaluation for Patients on VKA (Vitamin K Antagonist) Therapy (APTT, Immediate APTT Mixing Studies, Activated Protein C Resistance, Factor V Leiden Mutation, Anticardiolipin Antibody (IgG, IgM), Antithrombin Activity, Factor II Gene Mutation (Prothrombin G20210A), dRVVT, Hexagonal Phospholipid Neutralization, Homocysteine, Protein C Antigen, Protein S Antigen Total, Factor VII Antigen*RUO*, Factor VIII Activity, Protein C Antigen/Factor VII Antigen Ratio*RUO*, Protein S Antigen/Factor VII Antigen Ratio*RUO*, beta-2 Glycoprotein I IgG, IgA, IgM, Lupus Anticoagulant Interpretation) |
| 500334 |
Vitamin B-12 |
| 500342 |
Vitamin D, 1, 25-Dihydroxy |
| 500338 |
Vitamin D, 25-Hydroxy, Total, Mass Spectrometry |
| 500337 |
Vitamin D, 25-Hydroxy, Fractionated, Mass Spectrometry |
| 300910 |
von Willebrand Disease Evaluation
(APTT, Collagen Binding Ratio, von Willebrand Factor Collagen Binding Activity, Factor VIII Activity, von Willebrand Factor Activity, von Willebrand Factor Antigen) |
| 300114 |
von Willebrand Factor Activity
(Ristocetin Cofactor) |
| 300113 |
von Willebrand Factor Antigen
(Factor VIII Related Antigen) |
| 300117 |
von Willebrand Factor Multimers |
| 300115 |
von Willebrand Factor Type 2 N Binding*** |
| 300919 |
von Willebrand Inhibitor Profile
(Factor VIII Activity, von Willebrand Factor Antigen, von Willebrand Factor Activity, von Willebrand Activity NP Control, von Willebrand Activity 1:1 NP Mixing Study, von Willebrand Collagen Binding Activity, Collagen Binding ratio, Pathologist interpretation) |
| 500329 |
Thyroxine, Free by Dialysis and Mass Spectrometry |
| |
Free Thyroxine by Dialysis and Mass Spectrometry. See 500329 |
| 500130 |
C-Telopeptide |
| 304436 |
MTHFR C677T and A1298C (Methylenetetrahydrofolate Reductase; paired testing only) |
| 501881 |
Comprehensive GlycoMark® & A1C Profile |
| 501916 |
Thyroglobulin, Lymph Node Aspirate |
| 501836 |
Gonadotropin Releasing Hormone (GNRH), Mass Spectrometry |
| 304584 |
Clopidogrel CYP2C19 Genotype *RUO* |
| 304499 |
Activated Factor VII Activity *RUO* |
| 501847 |
Neo-Natal, 17-OHP, STAT |
| 500228 |
IGF-II |
| 500138 |
Dopamine, Urine (Includes Creatinine) |
| 502092 |
IPTH, Parathyroid Aspirate |
| 502087 |
Hemoglobin (Hgb) A1C with GlycoMark® Reflex |
| 300492 |
Plasminogen Activator Inhibitor-1 (PAI-1), Deficiency Evaluation (PAI-1 Activity, PAI-1 Antigen, Tissue Plasminogen Activator (TPA) Antigen) |
| 500333 |
Parathyroid Hormone-Related Peptide (PTHrP) |
| |
IA-2 Antibodies - see 500255, ICA-512 Autoantibodies |
| 300163 |
Antiphosphatidylserine Antibody, IgA |
| 300305 |
Antiphosphatidylserine Antibodies (APTS) IgG, IgM, IgA |
| 304910 |
von Willebrand Screening Profile (APTT, Factor VIII Activity, von Willebrand Factor Activity, von Willebrand Factor Antigen) |
| 500324 |
Resin T3 Uptake, Serum |
| |
T3 Uptake -see 500324 - Resin T3 Uptake, Serum |
| 500336 |
Triiodothyronine, Free by Dialysis and Mass Spectrometry |
| 804008 |
MEN2: RET Gene Sequencing |
| 804009 |
RET Gene Familial Mutation Analysis |
| 803610 |
Beta-Hydroxybutyrate |
| 302227 |
ADAMTS13 Activity Reflex Profile |
| 803640 |
Bile Acids, Fractionated LCMS |
| 803580 |
3-Epi-Vitamin D, 25-Hydroxy |
| 803658 |
Total and Free Progesterone |
| 803715 |
Cortisol-Cortisone Ratio Profile |
| 803725 |
Cortisone, Serum, LCMS |
| 803660 |
Insulin-Like Growth Factor (IGF-1), Pediatric with Z Score |
| |
Cortisol, Salivary - see 500094 - Salivary Cortisol, LC/MS-MS |
| |
Testosterone, Salivary - see 803765 - SalivaryTestosterone, LC/MS-MS |
| 803765 |
Salivary Testosterone, LC/MS-MS |
| 803835 |
Calciferols (Vitamin D), Total and Fractionated, LC/MS-MS |
| 803800 |
Thiopurine Metabolites |
